Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end‐stage renal disease-Reference-Cited by-同舟云学术

Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end‐stage renal disease

Published:2021-05-31 Issue:5 Volume:14 Page:2034-2042
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Tanaka Ryota¹,Suzuki Yosuke²,Watanabe Hiroshi³,Fujioka Takashi⁴,Hirata Kenshiro⁵,Shin Toshitaka⁶,Ando Tadasuke⁶,Ono Hiroyuki¹,Tatsuta Ryosuke¹,Mimata Hiromitsu⁶,Maruyama Toru³,Itoh Hiroki¹

Affiliation:

1. Department of Clinical Pharmacy Oita University Hospital Oita Japan

2. Department of Medication Use Analysis and Clinical Research Meiji Pharmaceutical University Tokyo Japan

3. Department of Biopharmaceutics Graduate School of Pharmaceutical Sciences Kumamoto University Kumamoto Japan

4. Laboratory of Medical Pharmaceutics Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Toyama Japan

5. Department of Clinical Pharmaceutics Faculty of Pharmaceutical Sciences Sojo University Kumamoto Japan

6. Department of Urology Faculty of Medicine Oita University Oita Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13065

Reference33 articles.

1. Annual Progress Report from the Japanese Renal Transplant Registry: number of renal transplantations in 2017 and a follow‐up survey;Japanese Society for Clinical Renal Transplantation/The Japan Society for Transplantation;JPN J Transplant,2018

2. New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation

3. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients

4. Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation

5. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana;BMC Research Notes;2024-07-29

2. Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction;Chemico-Biological Interactions;2024-03

3. Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms;British Journal of Clinical Pharmacology;2023-08-22

4. CYP metabolic pathway related gene polymorphism increases the risk of embolic and atherothrombotic stroke and vulnerable carotid plaque in southeast China;Journal of Stroke and Cerebrovascular Diseases;2023-08

5. Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease;Drug Design, Development and Therapy;2022-07